企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
Helixmith Co., Ltd is an R&D company established in 1996 that possesses tangible and intangible resources, capabilities, and an organization that surpass those of leading global biotech companies, spanning basic science such as candidate substance discovery and mechanism research through preclinical, analytical, process, production, quality control, regulatory, and clinical development stages. Based on global-level development experience gained through clinical trials in Korea and the United States, including U.S. FDA orphan drug and Fast Track designations and Regenerative Medicine Advanced Therapy (RMAT) designation, and abundant production, analytical, and clinical trial know-how gained through Phase 3 clinical trial experience in the United States, the company provides services based on various drug development platforms, including Plasmid DNA, Retrovirus, and AAV.
代表理事
Jang Songseon
成立日期
1996年11月21日
法人类型
韩国创业板
行业分类
Research and experimental development on medical sciences and pharmacy
法人注册号
11011-1343930
营业执照号
101-81-42428
电话号码
02-2102-7200
传真号码
02-887-0011
公司地址
21 Magokjungang 8-ro 7-gil, Gangseo-gu, Seoul
产品与服务
评论